Search

Search Results

• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  09-09-2016 Pages 57-64

  DOI https://doi.org/10.4081/reumatismo.2016.873

  • 3,827 abstract views
  • 2,485 PDF
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  06-11-2014 Pages 208-214

  DOI https://doi.org/10.4081/reumatismo.2014.756

  • 3,198 abstract views
  • 1,771 PDF
• 

  Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis

  F.M. Perrotta, G. Guerra, A. De Socio, S. Scriffignano, E. Lubrano

  22-05-2017 Pages 1-8

  DOI https://doi.org/10.4081/reumatismo.2017.976

  • 3,200 abstract views
  • 1,694 PDF
• 

  Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices

  F.M. Perrotta, A. Scarno, A. Carboni, V. Bernardo, M. Montepaone, E. Lubrano, A. Spadaro

  23-07-2013 Pages 105-112

  DOI https://doi.org/10.4081/reumatismo.2013.105

  • 3,447 abstract views
  • 1,316 PDF
• 

  Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

  A. Spadaro, A. Scarno, A. Carboni, F.M. Perrotta, C. Catalano, E. Lubrano, G. Valesini

  24-07-2013 Pages 134-137

  DOI https://doi.org/10.4081/reumatismo.2013.134

  • 2,992 abstract views
  • 938 PDF
• 

  Anifrolumab as a therapeutic option in mixed connective tissue disease with autoimmune cytopenia: a case report and narrative review of the literature

  Noemi Italiano, Fabio Massimo Perrotta, Mauro Fatica, Ennio Lubrano

  26-08-2026

  DOI https://doi.org/10.4081/reumatismo.2026.2395

  • 1,349 abstract views
  • 205 PDF
• 

  The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

  Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

  11-11-2024

  DOI https://doi.org/10.4081/reumatismo.2024.1688

  • 2,703 abstract views
  • 1,350 PDF

• Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review

  S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano

  24-09-2024

  DOI https://doi.org/10.4081/reumatismo.2024.1647

  • 1,437 abstract views
  • 588 PDF
• 

  Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab

  F.M. Perrotta, S. Scriffignano, M. Fatica, M. Specchia, E. Lubrano

  19-11-2020 Pages 178-181

  DOI https://doi.org/10.4081/reumatismo.2020.1297

  • 1,810 abstract views
  • 1,095 PDF
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  10-04-2020 Pages 52-59

  DOI https://doi.org/10.4081/reumatismo.2020.1266

  • 2,675 abstract views
  • 1,501 PDF
• 

  Occult axial involvement in patients with psoriatic arthritis mutilans: a case report

  F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano

  09-07-2019 Pages 88-91

  DOI https://doi.org/10.4081/reumatismo.2019.1146

  • 2,534 abstract views
  • 1,154 PDF